A carregar...
Clinical Trials for Disease-Modifying Therapies in Alzheimer’s Disease: A Primer, Lessons Learned, and a Blueprint for the Future(1)
Alzheimer’s disease (AD) has no currently approved disease-modifying therapies (DMTs), and treatments to prevent, delay the onset, or slow the progression are urgently needed. A delay of 5 years if available by 2025 would decrease the total number of patients with AD by 50% in 2050. To meet the defi...
Na minha lista:
| Publicado no: | J Alzheimers Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
IOS Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6004914/ https://ncbi.nlm.nih.gov/pubmed/29562511 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-179901 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|